<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen J</submitter><funding>Key Research and Development Program of Hunan Province</funding><funding>National Natural Science Foundation of China</funding><pagination>469</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8672154</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(1)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>Cognitive behavioral therapy (CBT) is now included in the treatment of patients with inflammatory bowel disease (IBD) in many settings. However, different clinical trials report different outcomes without consensus. This study aims to evaluate the impact of CBT on the mental state, quality of life and disease activity of patients with IBD.&lt;h4>Design&lt;/h4>Systematic review.&lt;h4>Methods&lt;/h4>This systematic review searched eligible studies from 1946 to December 8, 2019, in MEDLINE, EMBASE, CINAHL, Cochrane library, ClinicalTrials.gov, PsycINFO, Web of Science for eligible randomized controlled trials (RCT).&lt;h4>Results&lt;/h4>Among the initial identified 1807 references, 11 studies met inclusion criteria. CBT was shown to improve patient's quality of life and reduce the level of d</pubmed_abstract><journal>BMC gastroenterology</journal><pubmed_title>The physiological and psychological effects of cognitive behavior therapy on patients with inflammatory bowel disease before COVID-19: a systematic review.</pubmed_title><pmcid>PMC8672154</pmcid><funding_grant_id>81970494</funding_grant_id><funding_grant_id>2019SK2041</funding_grant_id><pubmed_authors>Xie Y</pubmed_authors><pubmed_authors>Chen J</pubmed_authors><pubmed_authors>Hesketh T</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Li R</pubmed_authors><pubmed_authors>Sun Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>The physiological and psychological effects of cognitive behavior therapy on patients with inflammatory bowel disease before COVID-19: a systematic review.</name><description>&lt;h4>Objective&lt;/h4>Cognitive behavioral therapy (CBT) is now included in the treatment of patients with inflammatory bowel disease (IBD) in many settings. However, different clinical trials report different outcomes without consensus. This study aims to evaluate the impact of CBT on the mental state, quality of life and disease activity of patients with IBD.&lt;h4>Design&lt;/h4>Systematic review.&lt;h4>Methods&lt;/h4>This systematic review searched eligible studies from 1946 to December 8, 2019, in MEDLINE, EMBASE, CINAHL, Cochrane library, ClinicalTrials.gov, PsycINFO, Web of Science for eligible randomized controlled trials (RCT).&lt;h4>Results&lt;/h4>Among the initial identified 1807 references, 11 studies met inclusion criteria. CBT was shown to improve patient's quality of life and reduce the level of d</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2026-05-07T20:16:21.076Z</modification><creation>2022-02-11T14:56:22.964Z</creation></dates><accession>S-EPMC8672154</accession><cross_references><pubmed>34911469</pubmed><doi>10.1186/s12876-021-02003-0</doi></cross_references></HashMap>